Literature DB >> 5576730

Effect of anti-oestrogens on initiation of mammary cancer in the female rat.

L Terenius.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5576730     DOI: 10.1016/0014-2964(71)90096-x

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  6 in total

1.  Suppression of DMBA-tumour induction in rat mammary glands by pregnancy or chlorotrianisene.

Authors:  J A Kellen
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1973

Review 2.  Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program.

Authors:  Lori M Minasian; Catherine M Tangen; D Lawrence Wickerham
Journal:  Semin Oncol       Date:  2015-07-10       Impact factor: 4.929

Review 3.  Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer.

Authors:  V Craig Jordan
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

Review 4.  Induced mammary cancer in rat models: pathogenesis, genetics, and relevance to female breast cancer.

Authors:  James L Miller; Arianna P Bartlett; Rebecca M Harman; Prabin Dhangada Majhi; D Joseph Jerry; Gerlinde R Van de Walle
Journal:  J Mammary Gland Biol Neoplasia       Date:  2022-07-29       Impact factor: 2.698

5.  Controlled release low dose medroxyprogesterone acetate (MPA) inhibits the development of mammary tumors induced by dimethyl-benz(a) anthracene in the rat.

Authors:  F Labrie; S Li; A Bélanger; J Côté; Y Mérand; M Lepage
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

Review 6.  Tamoxifen: catalyst for the change to targeted therapy.

Authors:  V Craig Jordan
Journal:  Eur J Cancer       Date:  2008-01       Impact factor: 9.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.